Five things for pharma marketers to know: Thursday, March 23, 2017

Share this content:

1. House lawmakers are expected to vote on the American Healthcare Act, the GOP's replacement legislation for Obamacare. There are concerns that Republicans may lack the votes to pass the bill. (WaPo)

2. Johnson & Johnson has halted advertising on YouTube over concerns that its content might be displayed adjacent to videos containing hate speech and terrorist propaganda. Verizon and AT&T have taken the same step, citing similar concerns. (AdAge)

3. A startup, The Mednet, has launched with the goal of becoming the “Quora of cancer care.” The forum will allow doctors to share information in a question-and-answer format, though privacy laws will prevent them from discussing specific patient cases. (TechCrunch)

4. Sanofi and Roche are expecting FDA-approval decisions next week. The FDA will weigh in on whether to approve Roche's multiple-sclerosis treatment Ocrevus and Sanofi's eczema drug Dupixent. (Reuters)

5. Valeant Pharmaceuticals International paid its CEO Josepha Papa $62.7 million last year. Papa joined the drugmaker in May amid a Congressional investigation and accounting irregularities. (WSJ)

Share this content:
Scroll down to see the next article